Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Al-Osaimi HM"'
Autor:
Al-Osaimi HM; Department of Pharmacy Services Administration, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia., Kanan M; Department of Clinical Pharmacy, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia., Marghlani L; Department of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia., Al-Rowaili B; Pharmaceutical Services Department, Northern Area Armed Forces Hospital, King Khalid Military, Hafr Al Batin, Kingdom of Saudi Arabia., Albalawi R; Department of Medicine, Tabuk University, Tabuk, Kingdom of Saudi Arabia., Saad A; Pharmacy Department, Royal Commission Hospital, Yanbu, Kingdom of Saudi Arabia., Alasmari S; Department of Clinical Pharmacy, King Khalid University, Jeddah, Kingdom of Saudi Arabia., Althobaiti K; Department of Medicine, Taif University, Ta'if, Kingdom of Saudi Arabia., Alhulaili Z; Department of Clinical Pharmacy, Dammam Medical Complex, Dammam, Kingdom of Saudi Arabia., Alanzi A; Department of Medicine, King Abdulaziz Hospital, Makkah, Kingdom of Saudi Arabia., Alqarni R; Department of Medicine and Surgery, King Khalid University, Abha, Kingdom of Saudi Arabia., Alsofiyani R; Department of Medicine, Taif University, Ta'if, Kingdom of Saudi Arabia., Shrwani R; Department of Clinical Pharmacy, Jazan University, Jazan, Kingdom of Saudi Arabia.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2337985. Date of Electronic Publication: 2024 Apr 11.